<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" VersionID="2" Owner="NLM"><PMID Version="2">33025327</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>26</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>1</Issue><PubDate><Year>2021</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Telemedicine for management of patients with amyotrophic lateral sclerosis through COVID-19 tail.</ArticleTitle><Pagination><StartPage>9</StartPage><EndPage>13</EndPage><MedlinePgn>9-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-020-04783-x</ELocationID><Abstract><AbstractText>Over the last months, due to coronavirus disease (COVID-19) pandemic, containment measures have led to important social restriction. Healthcare systems have faced a complete rearrangement of resources and spaces, with the creation of wards devoted to COVID-19 patients. In this context, patients affected by chronic neurological diseases, such as amyotrophic lateral sclerosis (ALS), are at risk to be lost at follow-up, leading to a higher risk of morbidity and mortality. Telemedicine may allow meet the needs of these patients. In this commentary, we briefly discuss the digital tools to remotely monitor and manage ALS patients. Focusing on detecting disease progression and preventing life-threatening conditions, we propose a toolset able to improve ALS management during this unprecedented situation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bombaci</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>"Rita Levi Montalcini" Department of Neuroscience, University of Torino, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Abbadessa</LastName><ForeName>Gianmarco</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8912-3055</Identifier><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, II Clinic of Neurology, University of Campania "Luigi Vanvitelli", Naples, Italy. gianmarcoabbadessa@live.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Digital Technologies, Web and Social Media Study Group of the Italian Society of Neurology, Via Pansini 5, 80131, Naples, Italy. gianmarcoabbadessa@live.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trojsi</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, I Clinic of Neurology, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Leocani</LastName><ForeName>Letizia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurorehabilitation, IRCCS San Raffaele Hospital, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University Vita-Salute San Raffaele, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonavita</LastName><ForeName>Simona</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, II Clinic of Neurology, University of Campania "Luigi Vanvitelli", Naples, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavorgna</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Advanced Medical and Surgical Sciences, I Clinic of Neurology, University of Campania "Luigi Vanvitelli", Naples, Italy. Luigilavorgna@policliniconapoli.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Digital Technologies, Web and Social Media Study Group of the Italian Society of Neurology</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018670" MajorTopicYN="Y">Monitoring, Ambulatory</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017216" MajorTopicYN="Y">Telemedicine</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS patients</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Remote monitoring</Keyword><Keyword MajorTopicYN="N">Tele-health</Keyword><Keyword MajorTopicYN="N">Telemedicine</Keyword><Keyword MajorTopicYN="N">Teleneurology</Keyword></KeywordList><CoiStatement>None.</CoiStatement><InvestigatorList><Investigator ValidYN="Y"><LastName>Tedeschi</LastName><ForeName>Gioacchino</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Mancardi</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Padovani</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Clerico</LastName><ForeName>Marinella</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Brigo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lanzillo</LastName><ForeName>Roberta</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Russo</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Giometto</LastName><ForeName>Bruno</ForeName><Initials>B</Initials></Investigator><Investigator ValidYN="Y"><LastName>Straccia</LastName><ForeName>Giulia</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iodice</LastName><ForeName>Rosa</ForeName><Initials>R</Initials></Investigator><Investigator ValidYN="Y"><LastName>Bucello</LastName><ForeName>Sebastiano</ForeName><Initials>S</Initials></Investigator><Investigator ValidYN="Y"><LastName>Annovazzi</LastName><ForeName>Pietro</ForeName><Initials>P</Initials></Investigator><Investigator ValidYN="Y"><LastName>Moccia</LastName><ForeName>Marcello</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Prosperini</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Stromillo</LastName><ForeName>Maria Laura</ForeName><Initials>ML</Initials></Investigator><Investigator ValidYN="Y"><LastName>Repice</LastName><ForeName>Anna Maria</ForeName><Initials>AM</Initials></Investigator><Investigator ValidYN="Y"><LastName>Miele</LastName><ForeName>Giuseppina</ForeName><Initials>G</Initials></Investigator><Investigator ValidYN="Y"><LastName>Lerario</LastName><ForeName>Alberto</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>De Martino</LastName><ForeName>Antonio</ForeName><Initials>A</Initials></Investigator><Investigator ValidYN="Y"><LastName>Iodice</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Di Lorenzo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials></Investigator><Investigator ValidYN="Y"><LastName>Cuffaro</LastName><ForeName>Luca</ForeName><Initials>L</Initials></Investigator><Investigator ValidYN="Y"><LastName>Romoli</LastName><ForeName>Michele</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Silvestro</LastName><ForeName>Marcello</ForeName><Initials>M</Initials></Investigator><Investigator ValidYN="Y"><LastName>Artusi</LastName><ForeName>Carlo Alberto</ForeName><Initials>CA</Initials></Investigator></InvestigatorList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>7</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33025327</ArticleId><ArticleId IdType="pmc">PMC7538170</ArticleId><ArticleId IdType="doi">10.1007/s10072-020-04783-x</ArticleId><ArticleId IdType="pii">10.1007/s10072-020-04783-x</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Director-General&#x2019;s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19%2D%2D-11-march-2020. </Citation></Reference><Reference><Citation>Technology enabled care services. Resource for Commissioners. January 2015. NHS Commissioning Assembly. https://www.england.nhs.uk/wp-content/uploads/2014/12/TECS_FinalDraft_0901.pdf</Citation></Reference><Reference><Citation>Waldman G, Mayeux R, Claassen J, Agarwal S, Willey J, Anderson E, Punzalan P, Lichtcsien R, Bell M, Przedborski S, Ulane C, Roberts K, Williams O, Lassman AB, Lennihan L, Thakur KT. Preparing a neurology department for SARS-CoV-2 (COVID-19): early experiences at Columbia University Irving Medical Center and the New York Presbyterian Hospital in New York City. Neurology. 2020;94:886&#x2013;891. doi: 10.1212/WNL.0000000000009519.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009519</ArticleId><ArticleId IdType="pmc">PMC7963356</ArticleId><ArticleId IdType="pubmed">32253352</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonavita S, Tedeschi G, Atreja A, Lavorgna L. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic. Neurol Sci. 2020;41(5):1007&#x2013;1009. doi: 10.1007/s10072-020-04391-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04391-9</ArticleId><ArticleId IdType="pmc">PMC7162735</ArticleId><ArticleId IdType="pubmed">32303856</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Prim. 2017;3(1):17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi V, Bombaci A, Zampedri L, et al. (2020) Plasma pNfH levels differentiate SBMA from ALS. Journal of Neurology, Neurosurgery and Psychiatry. 91(2). 10.1136/jnnp-2019-320624</Citation><ArticleIdList><ArticleId IdType="pubmed">31575607</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, Al-Chalabi A. Amyotrophic lateral sclerosis. N Engl J Med. 2017;377(2):162&#x2013;172. doi: 10.1056/NEJMra1603471.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller RG, Jackson CE, Kasarskis EJ, England JD, Forshew D, Johnston W, Kalra S, Katz JS, Mitsumoto H, Rosenfeld J, Shoesmith C, Strong MJ, Woolley SC, Quality Standards Subcommittee of the American Academy of Neurology Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2009;73(15):1218&#x2013;1226. doi: 10.1212/WNL.0b013e3181bc0141.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bc0141</ArticleId><ArticleId IdType="pmc">PMC2764727</ArticleId><ArticleId IdType="pubmed">19822872</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker L, Schr&#xf6;der C, Tan H, et al. Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R. J Neurol Neurosurg Psychiatry. 2020;91:75&#x2013;81. doi: 10.1136/jnnp-2019-321138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2019-321138</ArticleId><ArticleId IdType="pubmed">31558653</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry JD, Paganoni S, Carlson K, Burke K, Weber H, Staples P, Salinas J, Chan J, Green JR, Connaghan K, Barback J, Onnela JP. Design and results of a smartphone-based digital phenotyping study to quantify ALS progression. Ann Clin Transl Neurol. 2019;6(5):873&#x2013;881. doi: 10.1002/acn3.770.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.770</ArticleId><ArticleId IdType="pmc">PMC6529832</ArticleId><ArticleId IdType="pubmed">31139685</ArticleId></ArticleIdList></Reference><Reference><Citation>American Academy of Neurology. Telemedicine and remote care. AAN COVID-19 Neurol Resour. https://www.aan.com/tools-and-resources/practicing-neurologists-administrators/telemedicine-and-remote-care/. Accessed April 25, 2020</Citation></Reference><Reference><Citation>Pulley MT, Brittain R, Hodges W, Frazier C, Miller L, Matyjasik-Liggett M, Maurer S, Peters M, Solomon K, Berger AR. Multidisciplinary amyotrophic lateral sclerosis telemedicine care: the store and forward method. Muscle Nerve. 2019;59(1):34&#x2013;39. doi: 10.1002/mus.26170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.26170</ArticleId><ArticleId IdType="pubmed">29802746</ArticleId></ArticleIdList></Reference><Reference><Citation>Awadallah M, Janssen F, K&#xf6;rber B, Breuer L, Scibor M, Handschu R. Telemedicine in general neurology: interrater reliability of clinical neurological examination via audio-visual telemedicine. Eur Neurol. 2018;80(5&#x2013;6):289&#x2013;294. doi: 10.1159/000497157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000497157</ArticleId><ArticleId IdType="pubmed">30783053</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Gancedo L, Kelly ML, Lavrov A, et al. (2019) Objectively monitoring amyotrophic lateral sclerosis patient symptoms during clinical trials with sensors: observational study. J Med Internet Res. 21(12). 10.2196/13433</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6942190</ArticleId><ArticleId IdType="pubmed">31859676</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto A, Almeida JP, Pinto S, Pereira J, Oliveira AG, De Carvalho M. Home telemonitoring of non-invasive ventilation decreases healthcare utilisation in a prospective controlled trial of patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry. 2010;81(11):1238&#x2013;1242. doi: 10.1136/jnnp.2010.206680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2010.206680</ArticleId><ArticleId IdType="pubmed">20826878</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison KM, Yunusova Y, Campbell TF, Wang J, Berry JD, Green JR. (2018) The diagnostic utility of patient-report and speech-language pathologists&#x2019; ratings for detecting the early onset of bulbar symptoms due to ALS HHS Public Access. 10.1080/21678421.2017.1303515</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5530595</ArticleId><ArticleId IdType="pubmed">28355886</ArticleId></ArticleIdList></Reference><Reference><Citation>Wills AM, Garry J, Hubbard J, Mezoian T, Breen CT, Ortiz-Miller C, Nalipinski P, Sullivan S, Berry JD, Cudkowicz M, Paganoni S, Chan J, Macklin EA. Nutritional counseling with or without mobile health technology: a randomized open-label standard-of-care-controlled trial in ALS. BMC Neurol. 2019;19(1):104. doi: 10.1186/s12883-019-1330-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1330-6</ArticleId><ArticleId IdType="pmc">PMC6540456</ArticleId><ArticleId IdType="pubmed">31142272</ArticleId></ArticleIdList></Reference><Reference><Citation>Brearly TW, Shura RD, Martindale SL, Lazowski RA, Luxton DD, Shenal BV, Rowland JA. Neuropsychological test administration by videoconference: a systematic review and meta-analysis. Neuropsychol Rev. 2017;27(2):174&#x2013;186. doi: 10.1007/s11065-017-9349-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-017-9349-1</ArticleId><ArticleId IdType="pubmed">28623461</ArticleId></ArticleIdList></Reference><Reference><Citation>Vitacca M, Comini L, Tentorio M, Assoni G, Trainini D, Fiorenza D, Morini R, Bruletti G, Scalvini S. A pilot trial of telemedicine-assisted, integrated care for patients with advanced amyotrophic lateral sclerosis and their caregivers. J Telemed Telecare. 2010;16(2):83&#x2013;88. doi: 10.1258/jtt.2009.090604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/jtt.2009.090604</ArticleId><ArticleId IdType="pubmed">20139136</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto S, Quintarelli S, Silani V. New technologies and amyotrophic lateral sclerosis &#x2013; which step forward rushed by the COVID-19 pandemic? J Neurol Sci. 2020;418:117081. doi: 10.1016/j.jns.2020.117081.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117081</ArticleId><ArticleId IdType="pmc">PMC7403097</ArticleId><ArticleId IdType="pubmed">32882437</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghdam MRF, Vodovnik A, Hameed RA (2019) Role of telemedicine in multidisciplinary team meetings. J Pathol Inform;10:35. Published 2019 Nov 18. 10.4103/jpi.jpi_20_19</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6883478</ArticleId><ArticleId IdType="pubmed">31799021</ArticleId></ArticleIdList></Reference><Reference><Citation>De Marchi F, Cantello R, Ambrosini S, Mazzini L, CANPALS Study Group Telemedicine and technological devices for amyotrophic lateral sclerosis in the era of COVID-19. Neurol Sci. 2020;41(6):1365&#x2013;1367. doi: 10.1007/s10072-020-04457-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-020-04457-8</ArticleId><ArticleId IdType="pmc">PMC7240164</ArticleId><ArticleId IdType="pubmed">32440978</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, Baird WO, Partridge R, Cooper CL, Mawson S, Quinn A, Shaw PJ, Walsh T, Wolstenholme D, Mcdermott CJ. The TiM system: developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19(5&#x2013;6):351&#x2013;361. doi: 10.1080/21678421.2018.1440408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2018.1440408</ArticleId><ArticleId IdType="pubmed">29451026</ArticleId></ArticleIdList></Reference><Reference><Citation>Hobson EV, Baird WO, Bradburn M et al. (2019) Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study. BMJ Open;9(10):e028525. Published 2019 Oct 22. 10.1136/bmjopen-2018-028525</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6830633</ArticleId><ArticleId IdType="pubmed">31640993</ArticleId></ArticleIdList></Reference><Reference><Citation>Geronimo A, Simmons Z. Evaluation of remote pulmonary function testing in motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener. 2019;20(5&#x2013;6):348&#x2013;355. doi: 10.1080/21678421.2019.1587633.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2019.1587633</ArticleId><ArticleId IdType="pubmed">30957547</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci G, Baldanzi S, Seidita F, Proietti C, Carlini F, Peviani S, Antonini G, Vianello A, Siciliano G, Musumeci O, Toscano A, Ravaglia S, Moggio M, Comi G, Pegoraro E, Filosto M, Marrosu G, Maggi L, Liguori R, Massa R, di Iorio G, Servidei S, Angelini C, Mongini T. A mobile app for patients with Pompe disease and its possible clinical applications. Neuromuscul Disord. 2018;28(6):471&#x2013;475. doi: 10.1016/j.nmd.2018.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nmd.2018.03.005</ArticleId><ArticleId IdType="pubmed">29655528</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasta R, Moglia C, D&#x2019;Ovidio F, di Pede F, de Mattei F, Cabras S, Peotta L, Iazzolino B, Giusiano S, Manera U, Palumbo F, Bombaci A, Torrieri MC, Ilardi A, Mastro E, Arcari M, Solero L, Grassano M, Daviddi M, Matteoni E, Salamone P, Fuda G, Canosa A, Chi&#xf2; A, Calvo A (2020) Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration:1&#x2013;4. 10.1080/21678421.2020.1820043</Citation><ArticleIdList><ArticleId IdType="pubmed">32924624</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>